All News

2018

January

Media Release / Jan 22, 2018

AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More
Media Release / Jan 16, 2018

AveXis Announces Pricing of Public Offering of Common Stock

Read More
Media Release / Jan 16, 2018

AveXis Announces Proposed Public Offering of Common Stock

Read More
Media Release / Jan 16, 2018

AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy

Read More
Media Release / Jan 08, 2018

REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy

Read More
Media Release / Jan 04, 2018

AveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1

Read More

Key Releases

Ad hoc announcement pursuant to article 53 Listing Rules.

Learn More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More